nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—Subarachnoid haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.075	0.159	CcSEcCtD
Nimodipine—Disseminated intravascular coagulation—Riluzole—amyotrophic lateral sclerosis	0.0458	0.0972	CcSEcCtD
Nimodipine—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.0275	0.0584	CcSEcCtD
Nimodipine—Ileus—Riluzole—amyotrophic lateral sclerosis	0.0231	0.0491	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.0164	0.0347	CcSEcCtD
Nimodipine—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.0155	0.033	CcSEcCtD
Nimodipine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0293	CcSEcCtD
Nimodipine—CACNA1F—Alzheimers Disease—CASP12—amyotrophic lateral sclerosis	0.0138	0.0437	CbGpPWpGaD
Nimodipine—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.0137	0.029	CcSEcCtD
Nimodipine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0278	CcSEcCtD
Nimodipine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0253	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0252	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—GRN—amyotrophic lateral sclerosis	0.0117	0.0369	CbGpPWpGaD
Nimodipine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.011	0.0233	CcSEcCtD
Nimodipine—CACNB4—medulla oblongata—amyotrophic lateral sclerosis	0.0105	0.0492	CbGeAlD
Nimodipine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0222	CcSEcCtD
Nimodipine—NR3C2—hindbrain—amyotrophic lateral sclerosis	0.00991	0.0466	CbGeAlD
Nimodipine—CACNB4—spinal cord—amyotrophic lateral sclerosis	0.00935	0.0439	CbGeAlD
Nimodipine—AHR—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00927	0.0294	CbGpPWpGaD
Nimodipine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00913	0.0194	CcSEcCtD
Nimodipine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00892	0.0189	CcSEcCtD
Nimodipine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00866	0.0184	CcSEcCtD
Nimodipine—CACNB1—medulla oblongata—amyotrophic lateral sclerosis	0.00837	0.0393	CbGeAlD
Nimodipine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00837	0.0178	CcSEcCtD
Nimodipine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00822	0.0174	CcSEcCtD
Nimodipine—NR3C2—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00807	0.0255	CbGpPWpGaD
Nimodipine—CACNB3—medulla oblongata—amyotrophic lateral sclerosis	0.00803	0.0377	CbGeAlD
Nimodipine—CACNB4—nervous system—amyotrophic lateral sclerosis	0.00788	0.037	CbGeAlD
Nimodipine—CACNA1F—Alzheimers Disease—MAPT—amyotrophic lateral sclerosis	0.00773	0.0245	CbGpPWpGaD
Nimodipine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00763	0.0162	CcSEcCtD
Nimodipine—CACNB4—central nervous system—amyotrophic lateral sclerosis	0.00758	0.0356	CbGeAlD
Nimodipine—CACNB1—spinal cord—amyotrophic lateral sclerosis	0.00747	0.0351	CbGeAlD
Nimodipine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00746	0.0158	CcSEcCtD
Nimodipine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00742	0.0158	CcSEcCtD
Nimodipine—CACNB4—cerebellum—amyotrophic lateral sclerosis	0.00741	0.0348	CbGeAlD
Nimodipine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00688	0.0146	CcSEcCtD
Nimodipine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00661	0.014	CcSEcCtD
Nimodipine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00632	0.0134	CcSEcCtD
Nimodipine—CACNB1—nervous system—amyotrophic lateral sclerosis	0.00629	0.0295	CbGeAlD
Nimodipine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00618	0.0131	CcSEcCtD
Nimodipine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00609	0.0129	CcSEcCtD
Nimodipine—CACNB1—central nervous system—amyotrophic lateral sclerosis	0.00606	0.0284	CbGeAlD
Nimodipine—CACNB3—nervous system—amyotrophic lateral sclerosis	0.00603	0.0283	CbGeAlD
Nimodipine—CACNB4—brain—amyotrophic lateral sclerosis	0.00602	0.0283	CbGeAlD
Nimodipine—AHR—medulla oblongata—amyotrophic lateral sclerosis	0.00595	0.0279	CbGeAlD
Nimodipine—CACNB1—cerebellum—amyotrophic lateral sclerosis	0.00592	0.0278	CbGeAlD
Nimodipine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00584	0.0124	CcSEcCtD
Nimodipine—CACNB3—central nervous system—amyotrophic lateral sclerosis	0.00581	0.0273	CbGeAlD
Nimodipine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00573	0.0122	CcSEcCtD
Nimodipine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00572	0.0121	CcSEcCtD
Nimodipine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0057	0.0121	CcSEcCtD
Nimodipine—NR3C2—brainstem—amyotrophic lateral sclerosis	0.00568	0.0267	CbGeAlD
Nimodipine—CACNB3—cerebellum—amyotrophic lateral sclerosis	0.00568	0.0267	CbGeAlD
Nimodipine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00564	0.012	CcSEcCtD
Nimodipine—CACNA1S—Alzheimers Disease—CASP12—amyotrophic lateral sclerosis	0.00553	0.0175	CbGpPWpGaD
Nimodipine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00546	0.0116	CcSEcCtD
Nimodipine—CACNA1F—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.00545	0.0173	CbGpPWpGaD
Nimodipine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00532	0.0113	CcSEcCtD
Nimodipine—AHR—spinal cord—amyotrophic lateral sclerosis	0.0053	0.0249	CbGeAlD
Nimodipine—AHR—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.00523	0.0166	CbGpPWpGaD
Nimodipine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00521	0.011	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00504	0.0107	CcSEcCtD
Nimodipine—CACNB1—brain—amyotrophic lateral sclerosis	0.00481	0.0226	CbGeAlD
Nimodipine—CACNB3—brain—amyotrophic lateral sclerosis	0.00461	0.0217	CbGeAlD
Nimodipine—CACNA1D—Alzheimers Disease—CASP12—amyotrophic lateral sclerosis	0.00449	0.0142	CbGpPWpGaD
Nimodipine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.0043	0.00913	CcSEcCtD
Nimodipine—AHR—cerebellum—amyotrophic lateral sclerosis	0.00421	0.0198	CbGeAlD
Nimodipine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00413	0.00877	CcSEcCtD
Nimodipine—CACNB2—nervous system—amyotrophic lateral sclerosis	0.00405	0.019	CbGeAlD
Nimodipine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00399	0.00848	CcSEcCtD
Nimodipine—NR3C2—medulla oblongata—amyotrophic lateral sclerosis	0.00396	0.0186	CbGeAlD
Nimodipine—CACNA1C—Alzheimers Disease—CASP12—amyotrophic lateral sclerosis	0.00395	0.0125	CbGpPWpGaD
Nimodipine—CACNB4—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00393	0.0124	CbGpPWpGaD
Nimodipine—CACNB2—central nervous system—amyotrophic lateral sclerosis	0.0039	0.0183	CbGeAlD
Nimodipine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00386	0.00819	CcSEcCtD
Nimodipine—CACNB2—cerebellum—amyotrophic lateral sclerosis	0.00381	0.0179	CbGeAlD
Nimodipine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00371	0.00788	CcSEcCtD
Nimodipine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00368	0.00781	CcSEcCtD
Nimodipine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00368	0.0078	CcSEcCtD
Nimodipine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00776	CcSEcCtD
Nimodipine—CACNB4—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00363	0.0115	CbGpPWpGaD
Nimodipine—CACNA1F—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.00361	0.0114	CbGpPWpGaD
Nimodipine—CACNA1D—nervous system—amyotrophic lateral sclerosis	0.00354	0.0166	CbGeAlD
Nimodipine—NR3C2—spinal cord—amyotrophic lateral sclerosis	0.00353	0.0166	CbGeAlD
Nimodipine—CACNB4—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0035	0.0111	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.0035	0.0111	CbGpPWpGaD
Nimodipine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00736	CcSEcCtD
Nimodipine—AHR—brain—amyotrophic lateral sclerosis	0.00342	0.016	CbGeAlD
Nimodipine—CACNA1D—central nervous system—amyotrophic lateral sclerosis	0.00341	0.016	CbGeAlD
Nimodipine—CACNA1D—cerebellum—amyotrophic lateral sclerosis	0.00333	0.0157	CbGeAlD
Nimodipine—CACNA1C—nervous system—amyotrophic lateral sclerosis	0.00327	0.0154	CbGeAlD
Nimodipine—CACNB4—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0032	0.0101	CbGpPWpGaD
Nimodipine—CACNA1C—central nervous system—amyotrophic lateral sclerosis	0.00315	0.0148	CbGeAlD
Nimodipine—CACNB3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00314	0.00994	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—MAPT—amyotrophic lateral sclerosis	0.0031	0.00982	CbGpPWpGaD
Nimodipine—CACNB2—brain—amyotrophic lateral sclerosis	0.0031	0.0146	CbGeAlD
Nimodipine—CACNA1C—cerebellum—amyotrophic lateral sclerosis	0.00308	0.0145	CbGeAlD
Nimodipine—CACNB1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00306	0.00967	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00301	0.00953	CbGpPWpGaD
Nimodipine—CACNB4—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00298	0.00943	CbGpPWpGaD
Nimodipine—CACNB4—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00298	0.00943	CbGpPWpGaD
Nimodipine—NR3C2—nervous system—amyotrophic lateral sclerosis	0.00298	0.014	CbGeAlD
Nimodipine—CACNB3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0029	0.00918	CbGpPWpGaD
Nimodipine—NR3C2—central nervous system—amyotrophic lateral sclerosis	0.00287	0.0135	CbGeAlD
Nimodipine—CACNB1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00282	0.00893	CbGpPWpGaD
Nimodipine—NR3C2—cerebellum—amyotrophic lateral sclerosis	0.0028	0.0132	CbGeAlD
Nimodipine—CACNB3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0028	0.00886	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00278	0.00879	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00272	0.00862	CbGpPWpGaD
Nimodipine—CACNA1D—brain—amyotrophic lateral sclerosis	0.00271	0.0127	CbGeAlD
Nimodipine—CACNB4—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00268	0.00849	CbGpPWpGaD
Nimodipine—CACNB4—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00265	0.0084	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00265	0.0084	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.00264	0.00837	CbGpPWpGaD
Nimodipine—CACNB3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00256	0.00811	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—MAPT—amyotrophic lateral sclerosis	0.00252	0.00797	CbGpPWpGaD
Nimodipine—CACNA1C—brain—amyotrophic lateral sclerosis	0.0025	0.0117	CbGeAlD
Nimodipine—CACNB1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00249	0.00789	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00246	0.0078	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00245	0.00777	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00241	0.00762	CbGpPWpGaD
Nimodipine—CACNB3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00238	0.00754	CbGpPWpGaD
Nimodipine—CACNB3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00238	0.00754	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.00236	0.00748	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00234	0.00741	CbGpPWpGaD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—IGFBP3—amyotrophic lateral sclerosis	0.00232	0.00734	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00232	0.00733	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00232	0.00733	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.00231	0.0073	CbGpPWpGaD
Nimodipine—CACNA1F—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.0023	0.00727	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00228	0.00722	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00228	0.00722	CbGpPWpGaD
Nimodipine—NR3C2—brain—amyotrophic lateral sclerosis	0.00228	0.0107	CbGeAlD
Nimodipine—AHR—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00225	0.00713	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00222	0.00703	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—MAPT—amyotrophic lateral sclerosis	0.00221	0.00701	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.00219	0.00693	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00216	0.00684	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00214	0.00679	CbGpPWpGaD
Nimodipine—CACNB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00212	0.00672	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00209	0.00661	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.00208	0.00659	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00206	0.00653	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00203	0.00644	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00196	0.00621	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00192	0.00607	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00191	0.00604	CbGpPWpGaD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—ATF1—amyotrophic lateral sclerosis	0.00188	0.00595	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.00184	0.00584	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00182	0.00577	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00182	0.00577	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.00179	0.00568	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.00178	0.00563	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00177	0.00562	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00177	0.00562	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00177	0.00561	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00171	0.00541	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00168	0.00533	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.00165	0.00521	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00163	0.00515	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00158	0.00501	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00156	0.00495	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.00156	0.00494	CbGpPWpGaD
Nimodipine—CACNA1F—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.00147	0.00466	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00147	0.00465	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00145	0.0046	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00145	0.0046	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.00145	0.00459	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00143	0.00454	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00139	0.00441	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.00139	0.0044	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00136	0.0043	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.00132	0.00416	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.00131	0.00416	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00131	0.00415	CbGpPWpGaD
Nimodipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.0013	0.00412	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0013	0.0041	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.00128	0.00405	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00128	0.00404	CbGpPWpGaD
Nimodipine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00121	0.00567	CbGeAlD
Nimodipine—CACNB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0012	0.00379	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.00118	0.00372	CbGpPWpGaD
Nimodipine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00116	0.00546	CbGeAlD
Nimodipine—CACNB2—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.00113	0.00356	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00111	0.00353	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00111	0.00353	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00111	0.0035	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00111	0.0035	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.00107	0.00338	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.00103	0.00327	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00101	0.0032	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000993	0.00314	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000948	0.003	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00094	0.00298	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000937	0.00297	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000937	0.00297	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000922	0.00292	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000885	0.0028	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000884	0.0028	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000823	0.00261	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000804	0.00255	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000803	0.00254	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—DAO—amyotrophic lateral sclerosis	0.0008	0.00253	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000797	0.00252	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000761	0.00241	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000748	0.00237	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000726	0.0023	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000676	0.00214	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000676	0.00214	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000671	0.00212	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000668	0.00212	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000657	0.00208	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00064	0.00203	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00064	0.00203	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000618	0.00196	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000608	0.00192	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000606	0.00192	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000591	0.00187	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000585	0.00185	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000574	0.00182	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000562	0.00178	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000562	0.00178	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000559	0.00177	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000544	0.00172	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00054	0.00171	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000514	0.00163	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000511	0.00162	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—MMP9—amyotrophic lateral sclerosis	0.000494	0.00157	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000488	0.00155	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000483	0.00153	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.00048	0.00152	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000478	0.00151	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—DAO—amyotrophic lateral sclerosis	0.000463	0.00146	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000459	0.00145	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000449	0.00142	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—VEGFA—amyotrophic lateral sclerosis	0.000444	0.00141	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000422	0.00133	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—DAO—amyotrophic lateral sclerosis	0.000406	0.00129	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—MMP9—amyotrophic lateral sclerosis	0.000395	0.00125	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—MMP9—amyotrophic lateral sclerosis	0.000384	0.00122	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00037	0.00117	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—VEGFA—amyotrophic lateral sclerosis	0.000355	0.00112	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000353	0.00112	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000351	0.00111	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—VEGFA—amyotrophic lateral sclerosis	0.000345	0.00109	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000342	0.00108	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000337	0.00107	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000325	0.00103	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSR—amyotrophic lateral sclerosis	0.000324	0.00102	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00032	0.00101	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.000317	0.001	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000308	0.000975	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSR—amyotrophic lateral sclerosis	0.000284	0.0009	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000282	0.000893	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MMP9—amyotrophic lateral sclerosis	0.000282	0.000892	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000281	0.000888	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000274	0.000869	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000266	0.000841	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.000253	0.000802	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—VEGFA—amyotrophic lateral sclerosis	0.000253	0.000801	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000249	0.000788	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000249	0.000788	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000247	0.000781	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.000246	0.00078	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MMP9—amyotrophic lateral sclerosis	0.000241	0.000764	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000233	0.000739	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MMP9—amyotrophic lateral sclerosis	0.000229	0.000724	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000228	0.000721	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000227	0.000718	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VEGFA—amyotrophic lateral sclerosis	0.000217	0.000686	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000212	0.00067	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—amyotrophic lateral sclerosis	0.000205	0.00065	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000201	0.000636	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP9—amyotrophic lateral sclerosis	0.000201	0.000636	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000199	0.00063	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—APOE—amyotrophic lateral sclerosis	0.000187	0.000591	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.00018	0.000571	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—amyotrophic lateral sclerosis	0.00018	0.000571	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	0.00018	0.00057	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000172	0.000545	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000163	0.000517	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.000155	0.00049	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000151	0.000478	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000151	0.000477	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000149	0.000471	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.000146	0.000464	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000143	0.000454	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000143	0.000452	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000139	0.000439	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000136	0.000432	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000131	0.000415	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.000129	0.000408	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000128	0.000405	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000126	0.000398	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000125	0.000397	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000116	0.000366	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000116	0.000366	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000115	0.000365	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000114	0.000361	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—APOE—amyotrophic lateral sclerosis	0.000108	0.000342	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000106	0.000335	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000103	0.000327	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.84e-05	0.000311	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—APOE—amyotrophic lateral sclerosis	9.49e-05	0.0003	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	9.25e-05	0.000293	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	8.36e-05	0.000265	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.81e-05	0.000247	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.4e-05	0.000234	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.5e-05	0.000206	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	6.34e-05	0.000201	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	5.85e-05	0.000185	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.55e-05	0.000176	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.1e-05	0.000162	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.8e-05	0.000152	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	4.2e-05	0.000133	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.88e-05	9.11e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.58e-05	8.17e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.37e-05	7.51e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.95e-05	6.18e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.34e-05	4.23e-05	CbGpPWpGaD
